title: Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.
authors.forename: Blanca
authors.initials: B
authors.lastname: Xicoy
authors.forename: Pilar
authors.initials: P
authors.lastname: Miralles
authors.forename: Mireia
authors.initials: M
authors.lastname: Morgades
authors.forename: Rafael
authors.initials: R
authors.lastname: Rubio
authors.forename: María-Eulalia
authors.initials: ME
authors.lastname: Valencia
authors.forename: Josep-Maria
authors.initials: JM
authors.lastname: Ribera
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000401:mortality*; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans; D015996:Survival Rate / Q000639:trends; D013997:Time Factors; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin
keywords: HIV-related; Hodgkin’s lymphoma; long-term follow up; opportunistic infections; second cancers